InteRNA Technologies
PrivateLast Round
Series B
Extension
Feb 9, 2021
Total Funding Raised
$34.67M
Company Overview
InteRNA Technologies operates in Healthcare & Life Sciences and is based in Utrecht. Its latest recorded funding round was a Series B Extension round in February 2021.
InteRNA Technologies is a clinical-stage biotechnology company that develops microRNA-based therapeutics for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InteRNA Technologies Comparables
Compare InteRNA Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thalia Therapeutics PLC | 83% | |
| MiNA Therapeutics | 79% | |
| Novartis | 71% |
For institutional investors. Book with your work email.
InteRNA Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 9, 2021 | ||||
| Series A | Dec 15, 2015 | ||||
| Grant | Nov 18, 2010 |
For institutional investors. Book with your work email.
InteRNA Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AurorA Science | Series B Extension |
| Waterman Ventures | Series B Extension |
| East Netherlands Development Agency (Oost NL) | Series B Extension |
| Aglaia Oncology Funds | Series B Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2021
$22M round led by AurorA Science.
- Nov 18, 2010
Secured $1.77M in grant funding.
For institutional investors. Book with your work email.
InteRNA Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InteRNA Technologies's valuation, stock price, and market status.
Is InteRNA Technologies a public or private company?
InteRNA Technologies is a private company.
What is the current stock price of InteRNA Technologies?
InteRNA Technologies is a private company, so its shares have no public market price. Caplight tracks InteRNA Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InteRNA Technologies worth (valuation)?
Valuation information for InteRNA Technologies is not publicly available.
Can I buy InteRNA Technologies stock?
InteRNA Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InteRNA Technologies's last funding round?
InteRNA Technologies's most recent funding round was Series B Extension on February 9, 2021.
Who are the main investors in InteRNA Technologies?
Key investors in InteRNA Technologies include AurorA Science.
Will InteRNA Technologies IPO soon?
No public IPO plans have been announced for InteRNA Technologies.
How can I track InteRNA Technologies secondary market activity?
Caplight tracks bids, offers, and trades in InteRNA Technologies's shares on secondary markets.